DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In Vivo.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
26 May 2023
Historique:
received: 28 04 2023
revised: 20 05 2023
accepted: 22 05 2023
medline: 12 6 2023
pubmed: 10 6 2023
entrez: 10 6 2023
Statut: epublish

Résumé

Although the APOBEC3 family of single-stranded DNA cytosine deaminases is well-known for its antiviral factors, these enzymes are rapidly gaining attention as prominent sources of mutation in cancer. APOBEC3's signature single-base substitutions, C-to-T and C-to-G in TCA and TCT motifs, are evident in over 70% of human malignancies and dominate the mutational landscape of numerous individual tumors. Recent murine studies have established cause-and-effect relationships, with both human APOBEC3A and APOBEC3B proving capable of promoting tumor formation in vivo. Here, we investigate the molecular mechanism of APOBEC3A-driven tumor development using the murine

Identifiants

pubmed: 37298259
pii: ijms24119305
doi: 10.3390/ijms24119305
pmc: PMC10253583
pii:
doi:

Substances chimiques

APOBEC3A protein, human EC 3.5.4.5
Cytidine Deaminase EC 3.5.4.5
DNA 9007-49-2
APOBEC3B protein, human EC 3.5.4.5
Minor Histocompatibility Antigens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : P01 CA234228
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM118047
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM140936
Pays : United States
Organisme : NCI NIH HHS
ID : P01-CA234228
Pays : United States

Références

Mod Pathol. 2021 Feb;34(2):280-290
pubmed: 32632179
Nucleic Acids Res. 1996 Feb 1;24(3):478-85
pubmed: 8602361
J Virol. 2018 May 14;92(11):
pubmed: 29593034
Cell Cycle. 2016;15(7):998-1008
pubmed: 26918916
Nat Commun. 2016 Sep 21;7:12918
pubmed: 27650891
Nat Commun. 2017 Dec 4;8(1):1922
pubmed: 29203771
Nature. 2022 Jul;607(7920):799-807
pubmed: 35859169
Nat Commun. 2020 Jun 12;11(1):2971
pubmed: 32532990
Nat Genet. 2014 May;46(5):487-91
pubmed: 24728294
Blood. 2018 Sep 20;132(12):1304-1317
pubmed: 30061158
Sci Rep. 2017 Apr 21;7:46719
pubmed: 28429755
J Mol Biol. 2012 Jun 22;419(5):301-14
pubmed: 22446380
Cancer Res. 2017 Sep 1;77(17):4567-4578
pubmed: 28698210
Oncogene. 2016 Aug 18;35(33):4407-13
pubmed: 26640150
Hepatology. 2011 Mar;53(3):781-90
pubmed: 21374658
Nat Commun. 2015 Apr 21;6:6881
pubmed: 25898173
Nature. 2002 Jul 4;418(6893):99-103
pubmed: 12097915
Cancer Res. 2022 Oct 04;82(19):3435-3448
pubmed: 35930804
Nat Biotechnol. 2009 Mar;27(3):264-74
pubmed: 19234449
Nat Rev Cancer. 2017 Jun;17(6):381-392
pubmed: 28416802
Mol Cell. 2002 Nov;10(5):1247-53
pubmed: 12453430
PLoS One. 2017 Jan 31;12(1):e0171343
pubmed: 28141868
Nature. 2016 May 02;534(7605):47-54
pubmed: 27135926
Am J Hum Genet. 2002 Jan;70(1):38-50
pubmed: 11727199
Cancer Discov. 2015 Jul;5(7):704-12
pubmed: 26091828
J Inherit Metab Dis. 1998 Aug;21(5):518-31
pubmed: 9728332
Nat Rev Genet. 2018 Aug;19(8):473-490
pubmed: 29692414
Sci Rep. 2016 Jan 07;6:19035
pubmed: 26738439
Nucleic Acids Res. 2017 Apr 7;45(6):3231-3241
pubmed: 28100701
Am J Hum Genet. 1997 Feb;60(2):305-12
pubmed: 9012403
Nat Rev Cancer. 2021 Oct;21(10):619-637
pubmed: 34316057
Histopathology. 2023 Mar;82(4):608-621
pubmed: 36416305
Hepatology. 2008 May;47(5):1714-24
pubmed: 18435462
Nucleic Acids Res. 2018 Aug 21;46(14):e84
pubmed: 29746667
J Exp Med. 2003 May 5;197(9):1173-81
pubmed: 12732658
Blood Cancer J. 2021 Oct 8;11(10):166
pubmed: 34625538
ACS Synth Biol. 2021 May 21;10(5):1106-1115
pubmed: 33938211
CRISPR J. 2018 Jun;1:239-250
pubmed: 31021262
Nature. 2013 Feb 21;494(7437):366-70
pubmed: 23389445
Nat Rev Cancer. 2014 Dec;14(12):786-800
pubmed: 25568919
J Exp Med. 2020 Dec 7;217(12):
pubmed: 32870257
Viruses. 2013 Jul 30;5(8):1934-47
pubmed: 23903287
Nat Rev Genet. 2022 Aug;23(8):505-518
pubmed: 35256818
RNA Biol. 2021 Nov;18(11):1524-1539
pubmed: 33593231
Clin Cancer Res. 2020 Jul 1;26(13):3397-3407
pubmed: 32060098
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
PLoS One. 2016 Dec 15;11(12):e0168090
pubmed: 27977754
PLoS Genet. 2019 Dec 16;15(12):e1008545
pubmed: 31841499
Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8483-7
pubmed: 7667315
Nat Commun. 2023 Oct 11;14(1):6382
pubmed: 37821454
Nature. 2013 Feb 28;494(7438):492-496
pubmed: 23446422
Nat Genet. 2013 Sep;45(9):977-83
pubmed: 23852168
Nat Cell Biol. 2014 Jan;16(1):2-9
pubmed: 24366029
Cell Rep Med. 2023 Oct 17;4(10):101211
pubmed: 37797615
Antibodies (Basel). 2019 Sep 10;8(3):
pubmed: 31544853
Sci Rep. 2019 Jan 24;9(1):497
pubmed: 30679582

Auteurs

Jordan A Naumann (JA)

Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.
Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.

Prokopios P Argyris (PP)

Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.
Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Howard Hughes Medical Institute, University of Minnesota, Minneapolis, MN 55455, USA.
Division of Oral and Maxillofacial Pathology, College of Dentistry, Ohio State University, Columbus, OH 43210, USA.

Michael A Carpenter (MA)

Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
Howard Hughes Medical Institute, University of Texas Health San Antonio, San Antonio, TX 78229, USA.

Harshita B Gupta (HB)

Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.

Yanjun Chen (Y)

Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.

Nuri A Temiz (NA)

Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Institute for Health Informatics, University of Minnesota, Minneapolis, MN 55455, USA.

Yufan Zhou (Y)

Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.

Cameron Durfee (C)

Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.

Joshua Proehl (J)

Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.

Brenda L Koniar (BL)

Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.

Silvestro G Conticello (SG)

Core Research Laboratory, ISPRO, 50139 Florence, Italy.
Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.

David A Largaespada (DA)

Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA.

William L Brown (WL)

Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.
Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.

Hideki Aihara (H)

Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.
Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.

Rachel I Vogel (RI)

Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, MN 55455, USA.

Reuben S Harris (RS)

Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
Howard Hughes Medical Institute, University of Texas Health San Antonio, San Antonio, TX 78229, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH